Identifying facilitators and barriers to heart failure care in Haiti to adapt a community-based intervention

Information

  • Research Project
  • 10228008
  • ApplicationId
    10228008
  • Core Project Number
    K23HL140133
  • Full Project Number
    5K23HL140133-03
  • Serial Number
    140133
  • FOA Number
    PA-18-374
  • Sub Project Id
  • Project Start Date
    8/1/2019 - 5 years ago
  • Project End Date
    7/31/2023 - a year ago
  • Program Officer Name
    WILLIAMS, MAKEDA J
  • Budget Start Date
    8/1/2021 - 3 years ago
  • Budget End Date
    7/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    03
  • Suffix
  • Award Notice Date
    8/13/2021 - 3 years ago

Identifying facilitators and barriers to heart failure care in Haiti to adapt a community-based intervention

PROJEC T SUMMAR Y This proposal seeks to evaluate the biosocially complex interaction between heart failure (HF) patients and their health system to guide evidence-based interventions to improve wellbeing for patients in low- and middle- income countries (LMIC). Cardiovascular disease (CVD) causes 30% of all deaths in Haiti; nearly 4-times more deaths than human immunodeficiency virus (HIV). Our published work has shown that heart failure (HF) is the leading cause ? 37% ? of adult internal medicine hospitalizations. However, the crucial link from inpatient to outpatient care is not well developed as two-thirds of HF patients are not successfully linked to outpatient care, where linkage is defined as having a clinic visit within 30 days after discharge. My long-term career goal is to develop as an implementation scientist and test strategies to improve linkage to care for CVD in low-income countries. The objective of this application is to first identify barriers to poor linkage for patients hospitalized with HF in rural Haiti, and then to adapt and pilot an evidence-based CHW intervention to address the barriers based on models for HIV. My overarching hypotheses are that complex combinations of identifiable and modifiable biosocial and health system barriers influence how rural Haitian HF patients access care and that an adapted CHW intervention will enhance linkage to chronic care. The proposed research will be conducted in rural Haiti in collaboration with Partners In Health and Zanmi Lasante. Aim 1: Identify facilitators and barriers to outpatient care linkage for hospitalized HF patients. By assessing the salience of established and novel facilitators and barriers to HF care linkage from multiple perspectives, this aim will investigate what factors influence patients' decision and capacity to return for follow-up care. I will conduct a series of focus group discussions with 24-30 patients (stratified by those linked and not linked); 12-15 CHWs; and 8-12 doctors and nurses. I will identify central concepts categorized by the Consolidated Framework for Implementation Research, and also generate and refine hypotheses about facilitators and barriers to linkage. Aim 2: Adapt a CHW intervention to improve linkage to care for HF patients. By applying the findings from Aim 1 using the ADAPT-ITT framework, which has been successfully used to adapt care linkage strategies for HIV patients, I will modify an existing evidence-based CHW intervention used in HIV care for patients discharged after a HF admission based on the facilitators and barriers identified in Aim 1. Aim 3: Pilot the CHW intervention to assess feasibility and acceptability. I will pilot the adapted CHW linkage support intervention (Aim 2) with a sample of patients with HF (n=30) to improve linkage to care. I will use qualitative interviews and surveys among the patients, CHWs, doctors, nurses, and health system administrators to assess the acceptability, appropriateness, feasibility, and fidelity of the pilot intervention among all stakeholders. I will explore secondary effectiveness outcomes including linkage among the intervention group compared with a reference group of 30 HF patients.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    K23
  • Administering IC
    HL
  • Application Type
    5
  • Direct Cost Amount
    154700
  • Indirect Cost Amount
    10286
  • Total Cost
    164986
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    840
  • Ed Inst. Type
  • Funding ICs
    NHLBI:164986\
  • Funding Mechanism
    OTHER RESEARCH-RELATED
  • Study Section
    MPOR
  • Study Section Name
    NHLBI Mentored Patient-Oriented Research Review Committee
  • Organization Name
    BOSTON MEDICAL CENTER
  • Organization Department
  • Organization DUNS
    005492160
  • Organization City
    BOSTON
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    021182908
  • Organization District
    UNITED STATES